An investigator-initiated, non-randomised, phase II study of combination CTLA-4 and PD-L1 blockade in combination with HER2 blockade in advanced HER2-positive breast cancers that have progressed on prior trastuzumab-based therapy (BCT 1703 DIAmOND)
收藏DataCite Commons2024-08-21 更新2024-07-13 收录
下载链接：
https://doi.breastcancertrials.org.au/101
下载链接
链接失效反馈官方服务：
资源简介：
HeSANDA 1.0.0
提供机构：
Breast Cancer Trials (BCT)
创建时间：
2023-12-05
